Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit.
暂无分享,去创建一个
Laney K. Jones | Jennifer G. Robinson | Alan S. Brown | Dave L Dixon | A. Goldberg | E. Gill | J. Saseen | K. Maki | K. Aspry | D. Soffer | C. Orringer | M. Jayanna | L. Jones